Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Biomed Opt ; 17(8): 081412-1, 2012 Aug.
Article in English | MEDLINE | ID: mdl-23224173

ABSTRACT

Ovarian carcinoma has the highest lethality rate of gynecologic tumors, largely attributed to the late-stage diagnosis of the disease. Reliable tools for both accurate diagnosis and early detection of disease onset are lacking, and presently less than 20% of ovarian cancers are detected at an early stage. Protein biomarkers that allow the discrimination of early and late stages of ovarian serous carcinomas are urgently needed as they would enable monitoring pre-symptomatic aspects of the disease, disease progression, and the efficacy of intervention therapies. We compare the absolute and relative protein levels of six protein biomarkers for ovarian cancer in five different established ovarian cancer cell lines, utilizing both quantitative immunoblot analysis and a guided-mode resonance (GMR) bioassay detection system that utilizes a label-free optical biosensor readout. The GMR sensor approach provided highly accurate, consistent, and reproducible quantification of protein biomarkers as validated by quantitative immunoblotting, as well as enhanced sensitivity, and is therefore suitable for quantification and detection of novel biomarkers for ovarian cancer. We identified fibronectin, apolipoprotein A1, and TIMP3 as potential protein biomarkers for the differential diagnosis of primary versus metastatic ovarian carcinoma. Future studies are needed to confirm the suitability of protein biomarkers tested herein in patient samples.


Subject(s)
Biomarkers, Tumor/analysis , Biosensing Techniques/instrumentation , Immunoassay/instrumentation , Neoplasm Proteins/analysis , Ovarian Neoplasms/diagnosis , Ovarian Neoplasms/metabolism , Surface Plasmon Resonance/instrumentation , Equipment Design , Equipment Failure Analysis , Female , Humans , Nanotechnology/instrumentation , Reproducibility of Results , Sensitivity and Specificity , Staining and Labeling
2.
Hum Antibodies ; 20(3-4): 95-101, 2011.
Article in English | MEDLINE | ID: mdl-22129679

ABSTRACT

BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplasia and severe, recurrent epistaxis is a common clinical phenotype associated with HHT. An intranasal treatment regime of diluted Avastin™ (Bevacizumab; recombinant humanized anti-vascular epithelial growth factor immunoglobin G1) using apulsatile nasal irrigator has proven efficacious in clinical practice. However, concerns regarding the stability of Avastin™ following dilution and prolonged storage in standard containers used for drug delivery, such as polyethylene bottles, have so far prevented a more widespread clinical use. Compatibility with the preservative benzalkonium chloride was also unknown. OBJECTIVE: This study aimed at determining, whether dilution, prolonged refrigerated storage and the presence of the preservative benzalkonium chloride - as required for novel Avastin™ formulations - affected the biochemical and electrochemical properties of the drug. METHODS: We performed a detailed biochemical and electrochemical analysis of Avastin™, including native and sodium dodecyl sulfate polyacrylamide gel electrophoresis, enzyme-linked immunosorbent assay and isoelectric focusing. RESULTS: We did not detect any evidence of degeneration or aggregation following dilution and prolonged, refrigerated storage or from the presence of benzalkonium chloride. All biochemical and electrochemical properties of Avastin™ after dilution and prolonged, refrigerated storage were undistinguishable from control. CONCLUSIONS: Our data provide important insight into the stability of Avastin™ and allow the consideration of novel Avastin™ formulations, including its use in a metered-dose nasal spray for the treatment of HHT and other applications.


Subject(s)
Activin Receptors, Type II/immunology , Angiogenesis Inhibitors/immunology , Antibodies, Monoclonal, Humanized/immunology , Benzalkonium Compounds/chemistry , Epistaxis/drug therapy , Telangiectasia, Hereditary Hemorrhagic/drug therapy , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Activin Receptors, Type II/genetics , Administration, Intranasal , Angiogenesis Inhibitors/administration & dosage , Angiogenesis Inhibitors/therapeutic use , Antibodies, Monoclonal, Humanized/administration & dosage , Antibodies, Monoclonal, Humanized/therapeutic use , Bevacizumab , Drug Stability , Electrophoresis, Polyacrylamide Gel , Enzyme-Linked Immunosorbent Assay , Epistaxis/complications , Epistaxis/immunology , Epistaxis/metabolism , Humans , Isoelectric Focusing , Nasal Sprays , Polyethylene/chemistry , Preservatives, Pharmaceutical/chemistry , Telangiectasia, Hereditary Hemorrhagic/complications , Telangiectasia, Hereditary Hemorrhagic/immunology , Telangiectasia, Hereditary Hemorrhagic/metabolism , Vascular Endothelial Growth Factor A/immunology
3.
Invest Ophthalmol Vis Sci ; 52(8): 5605-11, 2011 Jul 29.
Article in English | MEDLINE | ID: mdl-21508103

ABSTRACT

PURPOSE: Lacrimal glands regulate the production and secretion of tear fluid. Dysfunction of lacrimal gland acinar cells can ultimately result in ocular surface disorders, such as dry eye disease. Ca(2+) homeostasis is tightly regulated in the cellular environment, and secretion from the acinar cells of the lacrimal gland is regulated by both cholinergic and adrenergic stimuli, which both result in changes in the cytosolic Ca(2+) concentration. We have previously described the detailed intracellular distribution of inositol-1,4,5-trisphosphate receptors (IP(3)Rs), and ryanodine receptors (RyRs) in lacrimal acinar cells, however, little is known regarding the expression and distribution of the third major class of intracellular Ca(2+) release channels, transient receptor potential polycystin family (TRPP) channels. METHODS: Studies were performed in adult lacrimal gland tissue of Swiss-Webster mice. Expression, localization, and intracellular distribution of TRPP Ca(2+) channels were investigated using immunocytochemistry, immunohistochemistry, and electron microscopy. The biophysical properties of single polycystin-2 channels were investigated using a planar lipid bilayer electrophysiology system. RESULTS: All channel-forming isoforms of TRPP channels (polycystin-2, polycystin-L, and polycystin-2L2) were expressed in adult mouse lacrimal gland. Subcellular analysis of immunogold labeling revealed strongest polycystin-2 expression on the membranes of the endoplasmic reticulum, Golgi, and nucleus. Biophysical properties of lacrimal gland polycystin-2 channels were similar to those described for other tissues. CONCLUSIONS: The expression of TRPP channels in lacrimal acinar cells suggests a functional role of the proteins in the regulation of lacrimal fluid secretion under physiological and disease conditions, and provides the basis for future studies focusing on physiology and pharmacology.


Subject(s)
Calcium Channels/physiology , Lacrimal Apparatus/metabolism , Lacrimal Apparatus/ultrastructure , Receptors, Cell Surface/physiology , TRPP Cation Channels/physiology , Tears/metabolism , Age Factors , Animals , Calcium/metabolism , Calcium Channels/metabolism , Cell Nucleus/physiology , Cell Nucleus/ultrastructure , Endoplasmic Reticulum/physiology , Endoplasmic Reticulum/ultrastructure , Exocytosis/physiology , Golgi Apparatus/physiology , Golgi Apparatus/ultrastructure , Male , Membrane Potentials/physiology , Mice , Microscopy, Electron , Receptors, Cell Surface/metabolism , TRPP Cation Channels/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...